299 related articles for article (PubMed ID: 18219529)
21. Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus.
Lam R; Hwang WT; Chennareddy S; Boursi B; Yang YX
Dig Dis Sci; 2024 May; 69(5):1834-1843. PubMed ID: 38517561
[TBL] [Abstract][Full Text] [Related]
22. Plasma enterolignans are associated with lower colorectal adenoma risk.
Kuijsten A; Arts IC; Hollman PC; van't Veer P; Kampman E
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1132-6. PubMed ID: 16775171
[TBL] [Abstract][Full Text] [Related]
23. The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer.
Oh SW; Kim YH; Choi YS; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Yun SH; Lee WY; Chun HK; Kim DH; Shim SG
Dis Colon Rectum; 2008 Jan; 51(1):56-61. PubMed ID: 18030529
[TBL] [Abstract][Full Text] [Related]
24. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients.
Durán-Nah JJ; Rodríguez-Morales A; Smitheram J; Correa-Medina C
Rev Invest Clin; 2008; 60(6):451-8. PubMed ID: 19378831
[TBL] [Abstract][Full Text] [Related]
25. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
26. Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus.
Tseng CH
Arch Intern Med; 2006 Jun; 166(11):1184-9. PubMed ID: 16772245
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
Wallace K; Byers T; Morris JS; Cole BF; Greenberg ER; Baron JA; Gudino A; Spate V; Karagas MR
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):464-7. PubMed ID: 12750244
[TBL] [Abstract][Full Text] [Related]
28. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
29. Insulin therapy and colorectal adenomas in patients with diabetes mellitus.
Wong P; Weiner MG; Hwang WT; Yang YX
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1833-40. PubMed ID: 22879206
[TBL] [Abstract][Full Text] [Related]
30. Smokers as a high-risk group: data from a screening population.
Anderson JC; Latreille M; Messina C; Alpern Z; Grimson R; Martin C; Hubbard P; Shaw RD
J Clin Gastroenterol; 2009 Sep; 43(8):747-52. PubMed ID: 19407663
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer incidence is low in patients following a colonoscopy.
Strock P; Mossong J; Scheiden R; Weber J; Heieck F; Kerschen A
Dig Liver Dis; 2011 Nov; 43(11):899-904. PubMed ID: 21831735
[TBL] [Abstract][Full Text] [Related]
32. Is cervical cancer a risk factor for colorectal neoplasia? Prevalence of colorectal adenoma in Korean patients with cervical cancer.
Kim YJ; Kim ES; Lee JE; Park WY; Kwon JS; Park KS; Cho KB; Jang BK; Chung WJ; Hwang JS; Park JC
Hepatogastroenterology; 2011; 58(109):1177-81. PubMed ID: 21937373
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of colorectal adenomas in women with breast cancer.
Ochsenkühn T; Bayerdörffer E; Meining A; Späth L; Mannes GA; Wiebecke B; Eiermann W; Sackmann M; Göke B
Digestion; 2005; 72(2-3):150-5. PubMed ID: 16172552
[TBL] [Abstract][Full Text] [Related]
34. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
[TBL] [Abstract][Full Text] [Related]
35. Cholelithiasis is a risk factor for colorectal adenoma.
Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Wada R; Mitsushima T; Omata M
Am J Gastroenterol; 2008 Nov; 103(11):2847-52. PubMed ID: 18684172
[TBL] [Abstract][Full Text] [Related]
36. Association of colorectal adenoma with components of metabolic syndrome.
Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
[TBL] [Abstract][Full Text] [Related]
37. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
Nau DP; Mallya U
Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854
[TBL] [Abstract][Full Text] [Related]
38. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients.
Tamer A; Karabay O; Ekerbicer H
Jpn J Infect Dis; 2006 Feb; 59(1):10-4. PubMed ID: 16495627
[TBL] [Abstract][Full Text] [Related]
40. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women.
Elwing JE; Gao F; Davidson NO; Early DS
Am J Gastroenterol; 2006 Aug; 101(8):1866-71. PubMed ID: 16790036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
